Other immunisation & vaccination

All Items

• ATAGI targeted review 2025: Immunisation considerations for immunocompromised people in Australia

  Xia Wang, Phoebe CM Williams, Ketaki Sharma, Helen Quinn, Sanjay Jayasinghe, Clayton Chiu, Kristine Macartney, Katie L Flanagan, Kristy Cooper, Benjamin W Teh, Michelle L Giles, Nigel W Crawford

• Measles epidemiology in Australia: 2014 to 2024 Erratum to Commun Dis Intell (2018) - https://doi.org/10.33321/cdi.2026.50.016

  Ms Lizzie Gorrell, Dr Benjamin G Polkinghorne, Prof. David N Durrheim

• Presymptomatic transmission, vaccine breakthrough and anonymous contacts: a cluster of mpox in Canberra, Australian Capital Territory, 2024

  Alexandra Marmor, Rachael Crane, Felicity Greenville, Julia Smythe, Cynthia Mathew, Timothy Sloan-Gardner, Joshua Anlezark

• ATAGI 2024 Annual Statement on Immunisation

  Katrina Nicolopoulos, Catherine Tran, Clayton Chiu, Alexandra Hendry, Kristine K Macartney, Michelle L Giles, Nigel W Crawford

• ATAGI 2025 Annual Statement on Immunisation

  Katrina Nicolopoulos, Saskia van der Kooi, Clayton Chiu, Alexandra Hendry, Kristine K Macartney, A/Prof. Katherine Gibney, Prof. Katie Flanagan, Michelle L Giles, Nigel W Crawford

• Infant respiratory syncytial virus (RSV) immunisation coverage in an Australian regional area, 1 May 2024 – 31 October 2025

  Dr William H Roughan, Mr Brett Cavanagh-Ochiai, Ms Donna Barnekow, Ms Kaylene Lottkowitz, Mr Keppel Schafer, Dr Laxmi Camadoo, Professor Nicolas R Smoll

• ATAGI Targeted Review 2024: Immunisation strategies for prevention and control of respiratory syncytial virus disease in Australia

  Dr Chisato Imai-Boulter, Dr Jean Li-Kim-Moy, Dr Jocelynne McRae, Dr Clayton Chiu, Dr Sanjay Jayasinghe, Prof. Kristine Macartney, Dr Katherine Gibney, Ms Karen Bellamy, Ms Kristy Cooper, Prof. Katie Flanagan, Prof. Michelle Giles, Dr Julia Marshall, Dr Nicholas Silberstein, A/Prof. Benjamin Teh, Dr Rosalind Webby, Prof. Nigel W Crawford

• Effectiveness of COVID-19 vaccine booster doses in adults aged 50 years and over during the Omicron period in Victoria, Australia

  Joshua Szanyi, Yue Yang, Jiaxu Zeng, Chris Clarke, Amanda K Buttery, Professor Tony Blakely

• Measles epidemiology in Australia: 2014 to 2024

  Ms Lizzie Gorrell, Dr Benjamin G Polkinghorne, Prof. David N Durrheim

• ATAGI Targeted Review 2023: Vaccination for prevention of influenza in Australia

  Chisato Imai, Sanjay Jayasinghe, Jocelynne McRae, Jean Li-Kim-Moy, Clayton Chiu, Kristine Macartney, Penelope Burns, Kristy Cooper, Allen C Cheng, Katherine Gibney, Michelle Giles, Cheryl Jones, Tony Korman, Bette Liu, Nigel W Crawford

• National Vaccine Safety Workshop: summary and draft recommendations

  Glenda Lawrence, National Centre for Immunisation Research and Surveillance

  378-380

• The impact of the National Shingles Vaccination Program on the epidemiology of herpes zoster among adults ≥ 60 years in Victoria, Australia

  Madeleine J Marsland, Anna Glynn-Robinson, Rebecca F Gang, Janet Strachan

• ATAGI 2023 Annual Statement on Immunisation

  Australian Technical Advisory Group on Immunisation (ATAGI) secretariat, Immunisation Branch, Australian Government, Madeline Valeri, Shireen Durrani, Catherine Tran, Clayton Chiu, Kristine K Macartney, Michelle L Giles, Nigel W Crawford

• Gaps in maternal influenza vaccine uptake in Northern Territory: A need for a year-round influenza vaccination campaign

  Priya Darshene Janagaraj , Pari Shanmuga Raman Gurusamy , Rosalind Webby

• ATAGI Targeted Review 2021: the national COVID-19 vaccination program

  Sanjay Jayasinghe, Cyra Patel, Lucy Armstrong, Clayton Chiu, Kristine Macartney, Katie Flanagan, Katherine Gibney, Michelle Giles, Nigel Crawford, Allen Cheng, Chris Blyth

• ATAGI Targeted Review 2022: Vaccination for prevention of herpes zoster in Australia

  Yuanfei Anny Huang, Jean Li-Kim-Moy, Sanjay Jayasinghe, Clayton Chiu, Kristine Macartney, Bette Liu, Penelope Burns, Michelle Giles, Nigel Crawford

• ATAGI 2022 Annual Statement on Immunisation

  Australian Technical Advisory Group on Immunisation, Catherine T Tran, Madeline Valeri, Clayton Chiu, Michelle L Giles, Allen C Cheng, Kristine K Macartney, Christopher C Blyth, Nigel W Crawford

• How accurately does the Australian Immunisation Register identify children overdue for vaccine doses?: A national cross-sectional study

  Lauren G Dalton, Kelley N Meder, Frank H Beard, Aditi Dey, Brynley P Hull, Kristine K Macartney, Peter B McIntyre

• SMS reminders to improve the uptake and timeliness of the primary immunisation series in infants: a multi-centre randomised controlled trial

  Kerry-Ann F O'Grady, Michelle Kaus, Lee Jones, Garry Boddy, Sheree Rablin, Jack Roberts, Daniel Arnold, Sarah Parfitt, Renee Johnson, Kerry K Hall, Sallyanne Le Gros-Wilson, Kaley Butten, Maee Tombs, Stephen B Lambert

• ATAGI 2021 Annual Statement on Immunisation Last updated: 19 September 2021

  Australian Technical Advisory Group on Immunisation, Catherine Tran, Clayton Chiu, Allen C. Cheng, Nigel W Crawford, Michelle L Giles, Kristine K Macartney, Christopher C Blyth

• High influenza vaccination uptake in Victorian healthcare workers in 2020

  Lyn-li Lim, Alex J Hoskins, Leon J Worth, Katherine C Walker, Ann L Bull, Noleen Bennett

• Influenza vaccination uptake in Australia in 2020: impact of the COVID-19 pandemic?

  Frank Beard, Alexandra Hendry, Kristine Macartney

• Immunisation coverage estimates

  Peter McIntyre, Brynley Hull

  268

• Identifying early changes in influenza vaccination uptake following a government funded immunisation program using a participatory community surveillance program

  Sarah A Moberley, Sandra J Carlson, David N Durrheim, Craig B Dalton

• SAEFVIC: Surveillance of adverse events following immunisation (AEFI) in Victoria, Australia, 2018

  Hazel J Clothier, Jock Lawrie, Georgina Lewis, Melissa Russell, Nigel W Crawford, Jim P Buttery

• Influenza vaccination uptake in our most vulnerable groups: how well are we protecting them in 2019?

  Frank Beard, Alexandra Hendry, Kristine Macartney

• Scientific evidence supporting recommendations on the use of the 9-valent HPV vaccine in a 2-dose vaccine schedule in Australia

  Peter Wnukowski-Mtonga, Sanjay Jayasinghe, Clayton Chiu, Kristine Macartney, Julia Brotherton, Basil Donovan, Madeline Hall, David W Smith, Karen Peterson, Sue Campbell-Lloyd, Christine Selvey, Michelle Giles, John Kaldor, Helen Marshall

• Influenza vaccination in pregnancy among a group of remote dwelling Aboriginal and Torres Strait Islander mothers in the Northern Territory: The 1+1 Healthy Start to Life study

  Lisa McHugh, Michael J Binks, Yu Gao, Ross M Andrews, Robert S Ware, Tom Snelling, Sue Kildea

• Influenza vaccination coverage in a population-based cohort of Australian-born Aboriginal and non-Indigenous older adults

  Amalie Dyda, Surendra Karki, Marlene Kong, Heather F Gidding, John M Kaldor, Peter McIntyre, Emily Banks, C Raina MacIntyre, Bette Liu

• Australian childhood immunisation coverage, 1 July 2015 and 30 June 2016 cohort, assessed as at 30 September 2016

  Alexandra J Hendry, National Centre for Immunisation Research and Surveillance

  106-108

• Evaluation of bacille Calmette-Guérin immunisation programs in Australia

  Gulam Khandaker, Frank H Beard, Aditi Dey, Chris Coulter, Alexandra J Hendry, Kristine K Macartney

  33-48

• Adverse events following immunisation with bacille Calmette-Guérin vaccination: baseline data to inform monitoring in Australia following introduction of new unregistered BCG vaccine

  Alexandra J Hendry, Aditi Dey, Frank H Beard, Gulam Khandaker, Richard Hill, Kristine K Macartney

  470-474

• Australian childhood immunisation coverage, 1 April 2015 to 31 March 2016 cohort, assessed as at 30 June 2016

  Alexandra Hendry, National Centre for Immunisation Research and Surveillance

  552-553

• Australian childhood immunisation coverage, 1 January to 31 December cohort, assessed as at 31 March 2016

  Alexandra Hendry, National Centre for Immunisation Research and Surveillance

  444-445

• Australian childhood immunisation coverage, 1 October to 30 September cohort, assessed as at 31 December 2015

  Alexandra Hendry, National Centre for Immunisation Research and Surveillance

  304-305

• Australian childhood immunisation coverage, 1 July to 30 June cohort, assessed as at 30 September 2015

  Alexandra Hendry, National Centre for Immunisation Research and Surveillance

  177-178

• Australian childhood immunisation coverage, 1 April 2014 to 31 March 2015, assessed as at 30 June 2015

  Brynley P Hull, National Centre for Immunisation Research and Surveillance

  626-627

• Pertussis immunisation in pregnancy: a summary of funded Australian state and territory programs

  Frank H Beard

  329-336

• Australian childhood immunisation coverage, assessed as at 31 March 2015

  Brynley P Hull, National Centre for Immunisation Research and Surveillance

  493-494

• Australian childhood immunisation coverage, 1 July to 30 September cohort, assessed as at December 2014

  Brynley P Hull, National Centre for Immunisation Research and Surveillance

  292-293

• Australian childhood immunisation coverage, 1 January to 31 March cohort, assessed as at 30 June 2014

  Brynley P Hull, National Centre for Immunisation Research and Surveillance

  165-166

• Australian childhood immunisation coverage, 1 April to 30 June cohort, assessed as at 30 September 2014

  Brynley P Hull, National Centre for Immunisation Research and Surveillance

  167-168

• Australian childhood immunisation coverage, 1 October to 31 December cohort, assessed as at 31 March 2014

  Brynley P Hull, National Centre for Immunisation Research and Surveillance

  260-261

• Australian childhood immunisation coverage, 1 July to 30 September cohort, assessed as at 31 December 2013

  Brynley P Hull, National Centre for Immunisation Research and Surveillance

  157-158

• Australian childhood immunisation coverage, 1 April to 30 June cohort, assessed as at 30 September 2013

  Brynley P Hull, National Centre for Immunisation Research and Surveillance

  85-86

• Australian childhood immunisation coverage, 1 January to 31 March cohort, assessed as at 30 June 2013

  Brynley P Hull, National Centre for Immunisation Research and Surveillance

  434-435

• Australian childhood immunisation coverage, 1 April to 30 June cohort, assessed as at 30 September 2012

  Brynley Hull, National Centre for Immunisation Research and Surveillance

  274-275

• Australian childhood immunisation coverage, 1 October to 31 December cohort, assessed as at 31 March 2013

  Brynley Hull, National Centre for Immunisation Research and Surveillance

  276-277

• A History of adolescent school-based vaccination in Australia

  Kirsten Ward, Helen Quinn, Robert Menzies, Peter McIntyre

  168-174

• Supplementary report: surveillance of adverse events following immunisation among children aged less than seven years in Australia, 1 January to 30 June 2012

  Deepika Mahajan, Jane Cook, Aditi Dey, Kristine Macartney, Rob Menzies

  130-135

• Adolescent school-based vaccination in Australia

  Kirsten Ward, Helen Quinn, Michael Bachelor, Vicki Bryant, Sue Campbell-Lloyd, Angela Newbound, Megan Scully, Rosalind Webby, Peter B McIntyre

  156-167

• Australian childhood immunisation coverage, 1 July to 30 September 2012 cohort, assessed as at 31 December 2012

  Brynley Hull, National Centre for Immunisation Research and Surveillance

  88-89

• Annual report: surveillance of adverse events following immunisation in Australia, 2011

  Deepika Mahajan, Jane Cook, Aditi Dey, Kristine Macartney, Rob Menzies

  315-332

• Supplementary report: surveillance of adverse events following immunisation among children aged less than seven years in Australia, 1 January to 30 June 2011

  Deepika Mahajan, Jane Cook, Peter McIntyre, Kristine Macartney, Rob Menzies

  114-119

• Surveillance of adverse events following immunisation: the model of SAEFVIC, Victoria

  Hazel J Clothier, Nigel W Crawford, Ann Kempe, Jim P Buttery

  294-298

• Catching up with the catch–up: HPV vaccination coverage data for Australian women aged 18–26 years from the National HPV Vaccination Program Register

  Julia Brotherton, Dorota Gertig, Genevieve Chappell, Lesley Rowlands, Marion Saville

  197-201

• Supplementary report: surveillance of adverse events following immunisation among children aged less than 7 years in Australia, 1 January to 30 June 2010

  Deepika Mahajan, Rob Menzies, Jane Cook, Kristine Macartney, Peter McIntyre

  21-28

• An Evaluation of the Australian National Serosurveillance Program

  Andrew Jardine, Shelley L Deeks, Mahomed S Patel, Robert I Menzies, Gwendolyn L Gilbert, Peter B McIntyre

  29-36

• Supplementary report: surveillance of adverse events following immunisation among children aged less than seven years in Australia, 1 January to 30 June 2009

  Deepika Mahajan, Rob Menzies, Ilnaz Roomiani, Glenda Lawrence

  49-53

• Supplementary report: surveillance of adverse events following immunisation among children aged <7 years in Australia, 1 January to 30 June 2008

  Glenda L Lawrence, Deepika Mahajan, Ilnaz Roomiani

  27-31